Increased insoluble amyloid-beta induces negligible cognitive deficits in old AppNL/NL knock-in mice

Manuscript Number: 

18-0410R2

Author(s): 
Zsuzsanna Callaerts-Vegh, Rudi D'Hooge, Bart De Strooper, Carlos G. Dotti, Takaomi C. Saido, Isabel H. Salas

Disclosures

Zsuzsanna Callaerts-Vegh

  • Nothing to Disclose

Rudi D'Hooge

  • Nothing to Disclose

Bart De Strooper

  • Consulting Fees:
    Bart De Strooper is consultant to Janssen Pharmaceutica, Eisai and Biogen
    Grants
    • Agency: 
      AbbVie
      Dates: 
      15.12.2016 to 15.12.2018
    • Agency: 
      Janssen Pharmaceutica
      Dates: 
      01.06.2017 to 31.05.2019

Carlos G. Dotti

  • Nothing to Disclose

Takaomi C. Saido

  • Nothing to Disclose

Isabel H. Salas

  • Nothing to Disclose